Hospitals and Clinics End User Segment to Dominate Creatinine Assay Market During Forecast Period

Increasing prevalence of diabetes and chronic kidney disorders to drive the growth of global creatinine assay market

According to TechSci Research report, “Global Creatinine Assay Market By Disease (Type 1 Diabetes, Type 2 Diabetes, Kidney disease, Others), By Method (O’Leary modified Jaffe assay, Jaffe, Enzymatic),By Kit (Creatinine-pap test kits, ELISA test kits, Jaffe’s kinetic test kits, Creatinine Colorimetric/Fluorometric Assay Kit), By Sample (Serum, Urine, Cerebrospinal fluid (CSF), Others), By End-User (Hospitals and clinics, Diagnostic laboratories, Others), By Region, Forecast & Opportunities, 2025”, the global creatinine assay market is expected to grow at a formidable rate during the forecast period on account of the increasing prevalence of diabetes, which has led to the increase in the number of patients suffering from renal diseases. Additionally, growing R&D activities coupled with an increase in the number of clinical laboratories around the globe is expected to propel the market during forecast years. Furthermore, improving healthcare facilities and growing awareness among the population pertaining to diabetes and renal diseases is expected to bolster the demand over the next few years. However, limited usage of creatinine assay kits in in vitro diagnostic devices can hampers the growth of market during the next five years. Additionally, discovery of new biomarkers for identification of renal dysfunction also restrict the growth of market through 2025. Furthermore, constantly changing regulatory policies are expected to obstruct the growth of market over next few years.

Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on Global Creatinine Assay Market”

https://www.techsciresearch.com/report/creatinine-assay-market/4535.html

The global creatinine assay market is segmented based on disease, method, kit, sample, end user, company and region. Based on method, the market can be fragmented into O’Leary modified jaffe assay, jaffe and enzymatic. The jaffe method is expected to hold a significant market share during forecast period on account of low cost of method and easy availability of the reagents and kits used in this method. Based on kit, the market can be categorized into creatinine-pap test kits, ELISA test kits, Jaffe’s kinetic test kits and creatinine colorimetric/fluorometric assay kit. The jaffe’s kinetic test kits segment dominates the market since jaffe’s method is the most conventional and most widely used method for measurement of creatinine. Hence, this increases the demand for jaffe’s kinetic test kits. Based on sample, the market can be grouped into serum, urine, cerebrospinal fluid (CSF) and others. The urine sample segment is expected to hold significant market share owing to ease of sample availability and non-invasive method of sample collection. The serum segment is expected to register the highest CAGR during the forecast period. This can be ascribed to the better results accuracy. Based on end user, the market can be segmented into hospitals and clinics, diagnostic laboratories and others. The hospitals and clinics segment are expected to dominate the market owing to the growing incidence of kidney diseases coupled with surge in number of hospital admissions. Furthermore, growing patient preference towards hospitals settings for disease detection and treatment will favor segment growth.

BioVision, Thermo Fisher Scientific, Merck, Bioassay Systems, Cell Biolabs, Fujifilm, Quidel Corporation, Enzo Life Sciences, Tulip Diagnostics, Genway Biotech, Crystal Chem, Randox Laboratories, Nova Biomedical, Cayman Chemical, Pfizer, DiaSys Diagnostic Systems, Abbexa, MedTest DX, Roche, Abcam and others are some of the leading players operating in global creatinine assay market. The companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4535

Customers can also request for 10% free customization on this report.

“Asia-Pacific is expected to witness the highest growth in the creatinine assay market during the forecast period, owing to the increasing prevalence of chronic kidney diseases, diabetes and ageing population. Additionally, economic growth in countries like India and China is supporting the health care infrastructure as well as expansion of pharmaceutical companies and biotech labs in these countries. Also, growing focus of market players on addressing demands in these countries is further expected to foster the growth of market through 2025.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

Global Creatinine Assay Market By Disease (Type 1 Diabetes, Type 2 Diabetes, Kidney disease, Others), By Method (O’Leary modified Jaffe assay, Jaffe, Enzymatic),By Kit (Creatinine-pap test kits, ELISA test kits, Jaffe’s kinetic test kits, Creatinine Colorimetric/Fluorometric Assay Kit), By Sample (Serum, Urine, Cerebrospinal fluid (CSF), Others), By End-User (Hospitals and clinics, Diagnostic laboratories, Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global creatinine assay market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global creatinine assay market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com